Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine
- Angew Chem Int Ed Engl. 2008;47(34):6395-8. doi: 10.1002/anie.200801885.
Affiliations
- 1. Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
PMID: 18624313
DOI: 10.1002/anie.200801885
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Toll-like Receptor (TLR)
-
target: Drug IntermediateResearch Areas: Others